DJIA 17,523.80 -159.78 -0.90%
NASDAQ 4,921.78 -70.16 -1.41%
S&P 500 2,051.82 -16.94 -0.82%
market minute promo

Perrigo Company (NYSE: PRGO)

183.13 -2.53 (-1.36%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

PRGO $183.26 -1.29%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $185.32
Previous Close $185.66
Daily Range $181.21 - $185.86
52-Week Range $135.00 - $215.73
Market Cap $26.8B
P/E Ratio 114.60
Dividend (Yield) $0.50 (0.3%)
Ex-Dividend Date
Dividend Pay Date
Volume 577,166
Average Daily Volume 1,149,774
Current FY EPS $7.32




Drug Makers

Perrigo Company (PRGO) Description

The Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients and consumer products. Website:

News & Commentary

Why Mylan NVs Mega-Merger Triangle Sent Its Shares Up 22% in April

Who will buy who? Mylan extends an offer for a rival, while a separate competitor makes a play for Mylan.

Today's Market: Teva Is A Committed Buyer, But Is Hewlett-Packard?

Benzinga's M&A Chatter for Monday July 6, 2015

Mergers and Acquisitions Boom Will Keep Rolling as Interest Rates Rise

Top Takeaways From BMO's Specialty Pharma Day

3 Stocks Raising The Health Care Sector Higher

Top Performing Industries For June 23, 2015

S&P 500 Movers: WYNN, PRGO

Benzinga's Top Initiations

Perrigo's Promising Future: 3 Compelling Reasons To Invest In Perrigo Company

Teva Announces Acquisition of 4.61% Interest in Mylan - Analyst Blog

Teva Announces Acquisition of 4.61% Interest in Mylan - Analyst Blog

See More PRGO News...

PRGO's Top Competitors

PRGO $183.13 (-1.36%)
Current stock: PRGO
JNJ $98.10 (-0.11%)
Current stock: JNJ
NVS $98.14 (-0.49%)
Current stock: NVS
RHHBY $34.46 (-1.81%)
Current stock: RHHBY